1. 方法論と範囲
1.1. 調査方法
1.2. 調査目的と調査範囲
2. 定義と概要
3. エグゼクティブ・サマリー
3.1. 製品タイプ別スニペット
3.2. 展開モード別スニペット
3.3. アプリケーション別スニペット
3.4. エンドユーザー別スニペット
3.5. 地域別スニペット
4. ダイナミクス
4.1. 影響要因
4.1.1. 推進要因
4.1.1.1. 遠隔医療と遠隔患者モニタリングの採用増加
4.1.1.2. 患者の転帰とケアの質の向上に対する需要の高まり
4.1.2. 阻害要因
4.1.2.1. データプライバシーとセキュリティへの懸念
4.1.3. 機会
4.1.4. 影響分析
5. 産業分析
5.1. ポーターのファイブフォース分析
5.2. サプライチェーン分析
5.3. 価格分析
5.4. 規制分析
5.5. SWOT分析
5.6. 技術分析
5.7. アンメット・ニーズ
6. 製品タイプ別
6.1. 製品紹介
6.1.1. 製品タイプ別市場規模分析および前年比成長率分析(%)
6.1.2. 市場魅力度指数（製品タイプ別
6.2. ソフトウェアソリューション
6.2.1. はじめに
6.2.2. 市場規模分析と前年比成長率分析(%)
6.2.3. 電子カルテ（EHR）
6.2.4. 診療管理ソフトウェア
6.2.5. 臨床判断支援システム（CDSS）
6.2.6. ロボティック・プロセス・オートメーション・ソフトウェア
6.2.7. その他
6.3. ハードウェアソリューション
6.3.1. ロボット手術システム
6.3.2. 自動薬局調剤システム
6.3.3. 患者監視装置
6.3.4. ウェアラブル健康機器
7. 展開モード別
7.1. 導入
7.1.1. 市場規模分析および前年比成長率分析（%）、展開モード別
7.1.2. 市場魅力度指数（デプロイメントモード別
7.2. オンプレミス*市場
7.2.1. 導入
7.2.2. 市場規模分析と前年比成長率分析(%)
7.3. クラウドベース
7.4. ハイブリッド
8. アプリケーション別
8.1. 導入
8.1.1. 用途別市場規模分析および前年比成長率分析(%)
8.1.2. 市場魅力度指数、用途別
8.2. 臨床自動化*市場
8.2.1. 導入
8.2.2. 市場規模分析と前年比成長率分析(%)
8.2.3. 診断とイメージング
8.2.4. 外科
8.2.5. 検査室
8.2.6. その他
8.3. 患者のモニタリングと関与
8.3.1. 遠隔患者モニタリング
8.3.2. 患者ポータル
8.3.3. 遠隔医療と遠隔健康
8.3.4. その他
8.4. 管理・運営の自動化
8.4.1. 患者スケジューリングと登録
8.4.2. スタッフ管理
8.4.3. その他
8.5. その他
9. エンドユーザー別
9.1. はじめに
9.1.1. 市場規模分析および前年比成長率分析(%), エンドユーザー別
9.1.2. 市場魅力度指数、エンドユーザー別
9.2. 病院と診療所
9.2.1. はじめに
9.2.2. 市場規模分析と前年比成長率分析(%)
9.3. 診断研究所と画像診断センター
9.4. 外来手術センター
9.5. 在宅介護施設
9.6. その他
10. 地域別
10.1. はじめに
10.1.1. 地域別市場規模分析および前年比成長率分析(%)
10.1.2. 市場魅力度指数、地域別
10.2. 北米
10.2.1. 序論
10.2.2. 主な地域別ダイナミクス
10.2.3. 市場規模分析および前年比成長率分析（%）, 製品タイプ別
10.2.4. 市場規模分析およびYoY成長率分析（%）：デプロイメントモード別
10.2.5. 市場規模分析および前年比成長率分析（%）, アプリケーション別
10.2.6. 市場規模分析およびYoY成長率分析(%)、エンドユーザー別
10.2.7. 市場規模分析および前年比成長率分析(%)、国別
10.2.7.1. 米国
10.2.7.2. カナダ
10.2.7.3. メキシコ
10.3. ヨーロッパ
10.3.1. はじめに
10.3.2. 主な地域別ダイナミクス
10.3.3. 市場規模分析および前年比成長率分析（%）, 製品タイプ別
10.3.4. 市場規模分析およびYoY成長率分析（%）：デプロイメントモード別
10.3.5. 市場規模分析および前年比成長率分析（%）, アプリケーション別
10.3.6. 市場規模分析およびYoY成長率分析(%)、エンドユーザー別
10.3.7. 市場規模分析および前年比成長率分析(%)、国別
10.3.7.1. ドイツ
10.3.7.2. イギリス
10.3.7.3. フランス
10.3.7.4. スペイン
10.3.7.5. イタリア
10.3.7.6. その他のヨーロッパ
10.4. 南米
10.4.1. はじめに
10.4.2. 地域別主要市場
10.4.3. 市場規模分析および前年比成長率分析（%）, 製品タイプ別
10.4.4. 市場規模分析およびYoY成長率分析（%）：デプロイメントモード別
10.4.5. 市場規模分析および前年比成長率分析（%）, アプリケーション別
10.4.6. 市場規模分析およびYoY成長率分析(%)、エンドユーザー別
10.4.7. 市場規模分析および前年比成長率分析(%)、国別
10.4.7.1. ブラジル
10.4.7.2. アルゼンチン
10.4.7.3. その他の南米諸国
10.5. アジア太平洋
10.5.1. 序論
10.5.2. 主な地域別ダイナミクス
10.5.3. 市場規模分析および前年比成長率分析（%）, 製品タイプ別
10.5.4. 市場規模分析およびYoY成長率分析（%）：デプロイメントモード別
10.5.5. 市場規模分析および前年比成長率分析（%）, アプリケーション別
10.5.6. 市場規模分析およびYoY成長率分析(%)、エンドユーザー別
10.5.7. 市場規模分析および前年比成長率分析(%)、国別
10.5.7.1. 中国
10.5.7.2. インド
10.5.7.3. 日本
10.5.7.4. 韓国
10.5.7.5. その他のアジア太平洋地域
10.6. 中東・アフリカ
10.6.1. 序論
10.6.2. 主な地域別ダイナミクス
10.6.3. 市場規模分析および前年比成長率分析（%）, 製品タイプ別
10.6.4. 市場規模分析およびYoY成長率分析（%）：デプロイメントモード別
10.6.5. 市場規模分析および前年比成長率分析（%）, アプリケーション別
10.6.6. 市場規模分析および前年比成長率分析（%）：エンドユーザー別
11. 競合情勢
11.1. 競争シナリオ
11.2. 市場ポジショニング／シェア分析
11.3. M&A分析
12. 企業プロフィール
12.1. Medtronic plc*
12.1.1. 会社概要
12.1.2. 製品ポートフォリオと内容
12.1.3. 財務概要
12.1.4. 主な展開
12.2. Stryker Corporation
12.3. Smith+Nephew
12.4. Koninklijke Philips N.V.
12.5. Thermo Fisher Scientific Inc.
12.6. Boston Scientific Corporation
12.7. Becton, Dickinson and Company
12.8. Ethicon, Inc.
12.9. Cisco Systems, Inc.
12.10. Abbott Laboratories
リストは網羅的ではありません
13. 付録
13.1. 会社概要とサービス
13.2. お問い合わせ

Overview
The global healthcare automation tools market reached US$ 43.71 billion in 2023 and is expected to reach US$ 94.81 billion by 2031 growing at a CAGR of 10.3% during the forecast period 2024-2031.

Healthcare automation tools refer to a suite of software and hardware solutions that streamline, enhance and sometimes fully automate repetitive or complex tasks within healthcare settings. By applying technologies such as artificial intelligence, robotic process automation, machine learning, Internet of Things and robotics, these tools help improve efficiency, accuracy, patient care quality and operational productivity.
Automation greatly lessens healthcare practitioners' administrative workload. Healthcare institutions may save time and personnel expenses by automating repetitive processes like data input, billing, and appointment scheduling. One medical practice, for example, claimed that automating paper-based chores saved them more than $4,000 a month. Furthermore, there is a clear trend toward automation for operational efficiency, as half of US healthcare providers want to implement robotic process automation (RPA) technology within the next three years.

Market Dynamics: Drivers
Rising adoption of telemedicine and remote patient monitoring
A growing aging population, the need for more effective management of chronic illnesses, and the growing desire for patient-centered care have all contributed to the recent surge in the popularity of telemedicine and remote patient monitoring (RPM). The COVID-19 pandemic hastened the adoption of these technologies even further, highlighting their importance in preserving access to healthcare in trying circumstances.
For instance, according to the Centers for Disease Control and Prevention (CDC), a significant percentage of medical specialists (27.4%) used telemedicine for 50% or more of their patient visits, compared to primary care physicians and surgical specialists. The majority of primary care physicians (76.7%) and medical specialists (73.1%) reported being able to provide comparable quality treatment during telemedicine consultations as they would in person, while around half of surgical specialists (50.6%) reported the same ability. This change reflects a larger trend. From 15.4% in 2019 to 86.5% in 2021, the percentage of doctors using telemedicine increased dramatically, demonstrating the swift change in healthcare delivery.
RPM and telemedicine both make use of automated data analytics, which enables medical professionals to glean insightful information from vast amounts of patient data. To support proactive and preventative care efforts, these automation technologies examine data for patterns, irregularities and predictive analytics.
For instance, the FDA-approved portable EKG equipment AliveCor KardiaMobile allows for real-time patient heart rate and rhythm monitoring and transmits this information to medical professionals. Early diagnosis and continuous illness care are made easier by automated analytics' ability to identify anomalies that cardiologists then analyze.
Moreover, it is impossible to ignore the financial advantages of these technologies. It has been demonstrated that remote patient monitoring may save medical expenses, which translates into savings of almost $8,375 per patient. This affordability is especially alluring as healthcare institutions work to control costs while enhancing patient outcomes. By facilitating real-time health monitoring and data analysis, artificial intelligence (AI) is incorporated into these platforms to expand their capabilities and further improve patient participation and service quality.

Restraints
Factors such as data privacy and security concerns, limited awareness and resistance, high maintenance and upkeep costs, ethical and legal concerns surrounding AI and robotic automation, complexity of implementation and integration, limited evidence and clinical validation for certain technologies and regulatory complexity are expected to hamper the healthcare automation tools market.
The security of sensitive patient data is one of the most urgent problems with healthcare automation. For instance, a Colorado-based pathology laboratory is notifying more than 1.8 million patients that their sensitive information was compromised - one of the largest breaches reported by a medical testing lab to US federal regulators, making the healthcare industry especially vulnerable to hackers.

Segment Analysis
The global healthcare automation tools market is segmented based on product type, deployment mode, application, end-user and region.
The software solutions from the product type segment accounted for approximately XX% of the global healthcare automation tools market share
The software solutions segment is expected to hold the largest market share over the forecast period, largely because of their flexibility, scalability and ability to address multiple aspects of healthcare operations and clinical workflows. Unlike hardware, which often requires specialized and costly equipment, software solutions can be integrated into existing systems, allowing healthcare providers to automate various processes with lower initial investments and minimal infrastructure changes.
Software solutions are highly adaptable and can be tailored for diverse applications within healthcare, including administrative tasks, clinical decision support, patient engagement and data analytics. As there is a strong demand for software solutions, many major players are focussing on launching software automation solutions.
In June 2024, Keragon announced that the company is officially launching out of stealth. It says it is the first no-code workflow automation platform designed specifically for the US healthcare industry. Currently, it is used by practices and clinics, fast-growing digital health startups, all the way up to hospitals & NASDAQ-listed companies, across the 50 states. The platform enables instant connection of various popular software used by healthcare practitioners (such as EHRs, healthcare CRMs, AI medical scribes, appointment scheduling & billing software). It has built-in personalised AI assistants that fuel faster automations with less hussle.
Government initiatives also support the growth of software solutions in healthcare automation. In the U.S., programs like the Promoting Interoperability Program incentivize healthcare providers to adopt certified EHR technology that meets specific interoperability standards. This regulatory framework encourages the use of integrated software solutions that improve data sharing and enhance care coordination among providers.

Geographical Analysis
North America accounted for approximately XX% of the global healthcare automation tools market share
North America region is expected to hold the largest market share over the forecast period owing to the strong technological infrastructure, high adoption of robotics and AI in healthcare and presence of leading market players and frequent product launches, these are the major factors expected to drive the healthcare automation tools market in the North America.
North America, particularly the United States has a highly developed healthcare IT and technological infrastructure, enabling seamless adoption of advanced automation tools. The region’s robust internet connectivity, high penetration of electronic health records and established telehealth networks make it easier for healthcare facilities to integrate automation solutions.
For instance, according to HealthIT.gov, as of 2021, nearly 9 in 10 (88%) of U.S. office-based physicians adopted electronic health records (EHR) and nearly 4 in 5 (78%) had adopted a certified EHR. This is a consistent trend since 2015. Since 2008, office-based physician adoption of any EHRs has more than doubled, from 42% to 88%. Since ONC and the CDC began tracking it in 2014, the percentage of office-based physicians who adopted a certified EHR increased from 74% to 78%.
The region leads in the adoption of robotics and AI in healthcare, particularly in surgical robotics, diagnostics and clinical decision support. Robotics and AI are used extensively in hospitals to improve surgical precision, diagnostic accuracy and patient monitoring. The U.S. has been a pioneer in robotic-assisted surgeries. For instance, Intuitive Surgical’s da Vinci Surgical System has performed over 10 million procedures globally, with the U.S. representing the largest market share, indicating strong demand for robotic-assisted surgeries in the U.S.

Market Segmentation
By Product Type
• Software Solutions
o Electronic Health Record (EHR)
o Practice Management Software
o Clinical Decision Support Systems (CDSS)
o Robotic Process Automation Software
o Others
• Hardware Solutions
o Robotic Surgical Systems
o Automated Pharmacy Dispensing Systems
o Patient Monitoring Devices
o Wearable Health Devices
By Deployment Mode
• On-premises
• Cloud-based
• Hybrid
By Application
• Clinical Automation
o Diagnosis and Imaging
o Surgical
o Laboratory
o Others
• Patient Monitoring and Engagement
o Remote Patient Monitoring
o Patient Portals
o Telemedicine and Telehealth
o Others
• Administrative and Operational Automation
o Patient Scheduling and Registration
o Staff Management
o Others
• Others
By End-User
• Hospitals and Clinics
• Diagnostic Laboratories and Imaging Centers
• Ambulatory Surgical Centers
• Homecare Settings
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o U.K.
o France
o Spain
o Italy
o Rest of Europe
• South America
o Brazil
o Argentina
o The rest of South America
• Asia-Pacific
o China
o India
o Japan
o South Korea
o Rest of Asia-Pacific
• Middle East and Africa

Competitive Landscape
The major global players in the healthcare automation tools market include Medtronic plc, Stryker Corporation, Smith+Nephew, Koninklijke Philips N.V., Thermo Fisher Scientific Inc., Boston Scientific Corporation, Becton, Dickinson and Company, Ethicon, Inc., Cisco Systems, Inc. Abbott Laboratories and among others.

Key Developments
 In October 2024, Microsoft launched new healthcare data and artificial intelligence tools, including a collection of medical imaging models, a healthcare agent service and an automated documentation solution for nurses. The tools aim to help healthcare organizations build AI applications quicker and save clinicians time on administrative tasks, a major cause of industry burnout.
 In October 2024, Visionet Ventures launched a transformative clinical care application that leverages ambient AI to streamline medical documentation and enhance the clinician and patient experience. Reteta is more than just automating documentation and processes it’s about bringing the joy of medicine back to healthcare professionals and pushing the envelope of possibilities with AI in healthcare.

Why Purchase the Report?
• To visualize the global healthcare automation tools market segmentation based on product type, deployment mode, application, end-user and region and understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of the healthcare automation tools market with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping is available in excel consisting of key products of all the major players.
The global healthcare automation tools market report would provide approximately 70 tables, 64 figures and 189 pages.

Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by Deployment Mode
3.3. Snippet by Application
3.4. Snippet by End-User
3.5. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rising Adoption of Telemedicine and Remote Patient Monitoring
4.1.1.2. Rising Demand for Improved Patient Outcomes and Quality of Care
4.1.2. Restraints
4.1.2.1. Data Privacy and Security Concerns
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. SWOT Analysis
5.6. Technology Analysis
5.7. Unmet Needs
6. By Product Type
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
6.1.2. Market Attractiveness Index, By Product Type
6.2. Software Solutions*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.2.3. Electronic Health Record (EHR)
6.2.4. Practice Management Software
6.2.5. Clinical Decision Support Systems (CDSS)
6.2.6. Robotic Process Automation Software
6.2.7. Others
6.3. Hardware Solutions
6.3.1. Robotic Surgical Systems
6.3.2. Automated Pharmacy Dispensing Systems
6.3.3. Patient Monitoring Devices
6.3.4. Wearable Health Devices
7. By Deployment Mode
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment Mode
7.1.2. Market Attractiveness Index, By Deployment Mode
7.2. On-premises*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Cloud-based
7.4. Hybrid
8. By Application
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Clinical Automation*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.2.3. Diagnosis and Imaging
8.2.4. Surgical
8.2.5. Laboratory
8.2.6. Others
8.3. Patient Monitoring and Engagement
8.3.1. Remote Patient Monitoring
8.3.2. Patient Portals
8.3.3. Telemedicine and Telehealth
8.3.4. Others
8.4. Administrative and Operational Automation
8.4.1. Patient Scheduling and Registration
8.4.2. Staff Management
8.4.3. Others
8.5. Others
9. By End-User
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.1.2. Market Attractiveness Index, By End-User
9.2. Hospitals and Clinics*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Diagnostic Laboratories and Imaging Centers
9.4. Ambulatory Surgical Centers
9.5. Homecare Settings
9.6. Others
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment Mode
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.7.1. U.S.
10.2.7.2. Canada
10.2.7.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment Mode
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.7.1. Germany
10.3.7.2. U.K.
10.3.7.3. France
10.3.7.4. Spain
10.3.7.5. Italy
10.3.7.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment Mode
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.7.1. Brazil
10.4.7.2. Argentina
10.4.7.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment Mode
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.7.1. China
10.5.7.2. India
10.5.7.3. Japan
10.5.7.4. South Korea
10.5.7.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment Mode
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. Medtronic plc*
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. Stryker Corporation
12.3. Smith+Nephew
12.4. Koninklijke Philips N.V.
12.5. Thermo Fisher Scientific Inc.
12.6. Boston Scientific Corporation
12.7. Becton, Dickinson and Company
12.8. Ethicon, Inc.
12.9. Cisco Systems, Inc.
12.10. Abbott Laboratories
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us

*** 医療自動化ツールの世界市場に関するよくある質問(FAQ) ***

・医療自動化ツールの世界市場規模は？
→DataM Intelligence社は2023年の医療自動化ツールの世界市場規模を437.1億米ドルと推定しています。

・医療自動化ツールの世界市場予測は？
→DataM Intelligence社は2031年の医療自動化ツールの世界市場規模を948.1億米ドルと予測しています。

・医療自動化ツール市場の成長率は？
→DataM Intelligence社は医療自動化ツールの世界市場が2024年～2031年に年平均10.3%成長すると展望しています。

・世界の医療自動化ツール市場における主要プレイヤーは？
→「Medtronic plc, Stryker Corporation, Smith+Nephew, Koninklijke Philips N.V., Thermo Fisher Scientific Inc., Boston Scientific Corporation, Becton, Dickinson and Company, Ethicon, Inc., Cisco Systems, Inc. Abbott Laboratoriesなど ...」を医療自動化ツール市場のグローバル主要プレイヤーとして判断しています。

※上記FAQの市場規模、市場予測、成長率、主要企業に関する情報は本レポートの概要を作成した時点での情報であり、最終レポートの情報と少し異なる場合があります。

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/